Prostatic Calculi (Investigational Adjunct)

Investigational adjunct for symptomatic prostatic calculi associated with chronic prostatitis; targeted antibiotics, alpha blockers, and selective transurethral resection remain evidence-based.

Tier C — InvestigationalИсследовательское применениеLast updated: 2026-05-26 · Reviewed by ASH Editorial Board

Краткая информация для пациента

Есть ли FDA-допуск для этого показания?: Not FDA-cleared for prostatic calculi. FDA cleared medicinal leeches only for venous congestion in microsurgical reconstruction (K040187, 2004). Use here is Tier C investigational; the prostate is anatomically inaccessible to topical agents.
Какие доказательства существуют?: Tier C (investigational). No controlled trials exist for hirudotherapy in prostatic calculi; only mention-level traditional-medicine references. Prostatic calculi are common incidental findings, often asymptomatic. If symptomatic and associated with chronic bacterial prostatitis, evidence-based management is prolonged culture-guided targeted antibiotic therapy, alpha-blockers for urinary symptoms, and selectively transurethral resection of the prostate (TURP) for refractory cases.
Основные риски: Bleeding from bite sites for 6 to 24 hours after detachment
Bruising and tenderness over the perineum for 5 to 14 days
Local skin infection or Aeromonas infection in a region with frequent bacterial colonization
Compounding bacterial prostatitis if untreated infection is present
Allergic reaction to leech saliva
Delay of evidence-based culture-guided antibiotics, alpha-blockers, or TURP
Hypothetical risk if a leech detaches near the urethra (urethral bleeding)
Кому не следует это рассматривать: Anyone with untreated bacterial prostatitis (treat infection first)
Anyone with an indwelling urinary catheter
Anyone within the recovery window of prostate biopsy or surgery
Patients who cannot maintain perineal cleanliness during the bleeding window
Patients on anticoagulants or with severe anemia
Patients offered trans-rectal or peri-urethral placement (these are not appropriate)
О чём спросить врача: Has bacterial prostatitis been ruled out by culture, and what antibiotic course has been completed?
Have I had pelvic imaging to confirm calculi as the symptomatic driver?
Have alpha-blockers been trialed for symptom relief?
Has TURP been considered for refractory symptoms?
Where exactly will the leech be placed — confirm it is perineal skin only, not trans-rectal?
What is the realistic expected benefit, given the prostate is anatomically deep and inaccessible to topical agents?
Когда срочно обратиться за медицинской помощью: Inability to urinate (acute urinary retention)
Fever above 38.0 C / 100.4 F, chills, or rigors
Visible blood in urine or perineal hematoma
Severe lower abdominal or pelvic pain
Bleeding from a bite site lasting more than 24 hours
Spreading redness, warmth, pus, or red streaks at the bite site

Что это НЕ означает

It does not dissolve or remove prostatic stones — the prostate is too deep for topical effects.
It does not replace targeted antibiotic therapy when prostatic calculi harbor bacterial biofilms.
It does not substitute for TURP when refractory disease warrants surgical management.
Only anecdotal mention exists in traditional-medicine literature.

Перекрёстные ссылки безопасности

Clinical Profile

Category: urogenital
ICD-10: N42.0, N41.1
Safety tier: high

Evidence Summary

Prostatic calculi are common incidental findings, often asymptomatic, but in some patients harbor biofilms that perpetuate chronic bacterial prostatitis. Evidence-based management depends on context: if asymptomatic, observation only. If associated with chronic prostatitis, prolonged targeted antibiotic therapy guided by culture, alpha-blockers for urinary symptoms, and (selectively) transurethral resection of the prostate (TURP) for refractory cases. No published controlled trials of hirudotherapy exist for prostatic calculi. The prostate is anatomically deep and inaccessible to topical agents; any rationale for hirudotherapy is purely speculative. Perineal placement carries infection risk in this often-bacterial context.

Treatment specifics

How many leeches, where they are placed, how long a session lasts, and whether to repeat are clinical decisions made by a qualified provider under institutional protocol — not something to self-administer. Discuss the specifics with a clinician experienced in medicinal leech therapy. (Clinicians: switch the audience selector in the top bar to “Clinician” to view protocol detail.)

Contraindications

Active anticoagulant therapy (warfarin INR >2.0, DOACs, heparin)
Hemophilia or other bleeding disorder
Severe anemia (Hb <10 g/dL)
Active bacteremia or sepsis
Known hypersensitivity to leech salivary proteins
Pregnancy (relative — first/third trimester)
Immunocompromised state with severe neutropenia
Untreated bacterial prostatitis (treat infection first)
Indwelling urinary catheter
Recent prostate biopsy or surgery
Patient unable to maintain perineal cleanliness during bleed

Related Conditions

Peyronie's Disease (Stable Phase)

Investigational use for stable-phase Peyronie's disease; case-report-level evidence only. Standard treatments (verapamil, collagenase, surgery) remain first-line.

Chronic Prostatitis / Chronic Pelvic Pain Syndrome (CP/CPPS)

Investigational use for category III CP/CPPS; small case series suggest symptom reduction. Multimodal therapy remains standard.

Chronic Prostatitis / Chronic Pelvic Pain Syndrome (Extended Protocol)

Investigational extended-protocol adjunct for NIH Category III chronic prostatitis/CPPS; small case series only; UPOINT-directed therapy remains primary.

Interstitial Cystitis / Bladder Pain Syndrome (Investigational)

Highly investigational adjunct for IC/BPS refractory to conventional therapy; case reports only; AUA-guideline stepwise therapy remains primary.